US Patent Issued to Regeneron Pharmaceuticals on July 29 for "Nucleic acids encoding anchor modified antibodies and uses thereof" (New York, Georgia, Massachusetts, Maryland Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,475, issued on July 29, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Nucleic acids encoding anchor modified antibodies and uses thereof" was invented by Jason Mastaitis (Yorktown Heights, N.Y.), Andrew J. Murphy (Croton-on-Hudson, N.Y.), John McWhirter (Savannah, Ga.), Vera Voronina (North Bethesda, Md.) and Jesper Gromada (Concord, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are anchor-modified immunoglobulin polypeptides, wherein the anchor moors the immunoglobulin polypeptide to a receptor of interest. The anchor-modified immunoglobulin polypeptides are generally characterized at the N-terminus with...